| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | EP0957100B1 Diamine derivatives and pharmaceutical containing the same |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541204A Process to produce halo-4-phenoxyquinolines |
| 10/27/2004 | CN1539816A IL-8 receptor antagonist |
| 10/27/2004 | CN1172917C Steroid receptor modulator compounds and methods |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809106 Antiproliferation agents; such as 4-(2-methoxyphenoxy)-anilino-3-chloro-6,7-dimethoxyquinoline |
| 10/26/2004 | US6809097 Antiangiogenic and/or vascular permeability |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089907A1 Process for producing quinoline compound |
| 10/21/2004 | WO2004089885A1 Novel compounds |
| 10/21/2004 | WO2004089366A1 Bicyclic compounds as nr2b receptor antagonists |
| 10/21/2004 | WO2004089293A2 Hydroxamic acid compounds and methods of use thereof |
| 10/21/2004 | US20040209936 Compounds that modulate PPAR activity and methods of preparation |
| 10/21/2004 | US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 10/21/2004 | US20040209905 Quinoline derivatives and quinazoline derivatives |
| 10/21/2004 | US20040209902 Aminoquinoline compounds |
| 10/21/2004 | US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example |
| 10/21/2004 | CA2521907A1 Bicyclic compounds as nr2b receptor antagonists |
| 10/21/2004 | CA2521238A1 Process for producing quinoline compound |
| 10/21/2004 | CA2520611A1 Hydroxamic acid compounds and methods of use thereof |
| 10/20/2004 | EP0862554B1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 10/20/2004 | CN1171873C Preparation method of Menlust sodium and its preparation intermediate |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/20/2004 | CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides |
| 10/19/2004 | US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds |
| 10/19/2004 | US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects |
| 10/19/2004 | US6806276 2-oxoquinoline compounds and pharmaceutical uses thereof |
| 10/19/2004 | US6806274 Quinazoline derivatives |
| 10/14/2004 | WO2004087688A1 Novel crystalline forms of gatifloxacin |
| 10/14/2004 | WO2004087687A1 Chromene derivatives as anti-inflammatory agents |
| 10/14/2004 | WO2004087686A2 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | WO2004087670A1 Process for synthesis of bis-(substituted 4 quinolyl) disulphides |
| 10/14/2004 | WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/14/2004 | WO2004087668A1 A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones |
| 10/14/2004 | WO2004087142A1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 10/14/2004 | WO2004037853A3 Quinolones with anti-hiv activity |
| 10/14/2004 | US20040204587 Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolones |
| 10/14/2004 | US20040204586 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/14/2004 | US20040204451 Prevention reproduction of virus |
| 10/14/2004 | US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia |
| 10/14/2004 | US20040204409 Useful as antagonists of NMDA (N-methyl-D-aspartate) NR2B receptor; for therapy of pain, stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, depression, anxiety, migraine |
| 10/14/2004 | US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders |
| 10/14/2004 | CA2520724A1 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | CA2519291A1 Chromene derivatives as anti-inflammatory agents |
| 10/14/2004 | CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/13/2004 | EP1466905A1 Process for producing optically active oxoheptenoic acid ester |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466625A1 Preventives/remedies for urinary disturbance |
| 10/13/2004 | EP1466603A2 Novel catechols as antimicrobial agents |
| 10/13/2004 | EP1466506A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1005458B1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | CN1536992A Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 10/13/2004 | CN1536961A Agrochemical compositions with quinoline safeners |
| 10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
| 10/12/2004 | US6803469 Cyclizing in the presence of a silylating agent |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/07/2004 | WO2004085402A1 Ring-substituted 8-aminoqunoline derivates as antimalarial agents |
| 10/07/2004 | WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors |
| 10/07/2004 | WO2003068748A9 Novel pyridine- and quinoline-derivatives |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/06/2004 | EP1464641A1 4-Phenyl-piperazinyl, -piperidinyl and tetrahydropyridyl derivatives as dopamine D4 antagonists |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463495A2 Agents and methods for treatment of cancer |
| 10/06/2004 | EP1098864B1 Method for hydrogenating unsaturated heterocyclic compounds |
| 10/06/2004 | EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 10/06/2004 | CN1535151A Novel anti-infectives |
| 10/06/2004 | CN1534021A Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery |
| 10/06/2004 | CN1534016A Calcium acceptor active compound |
| 10/06/2004 | CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition |
| 10/06/2004 | CN1169794C 4-quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance. |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800643 Mixtures for organic compounds for the treatment of airway diseases |
| 10/05/2004 | US6800380 Organometallic luminescent materials and organic electroluminescent device containing same |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 09/30/2004 | WO2004083204A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/30/2004 | WO2004083183A1 Novel crystalline forms of aripiprazole |
| 09/30/2004 | WO2003022785A3 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192915 Process for preparing aripiprazole |
| 09/30/2004 | US20040192783 Use of B-2 bronchodilator drugs |
| 09/30/2004 | US20040192728 Antiinflammatory agents; analgesics |
| 09/30/2004 | US20040192724 Process for preparation of ring-substituted 8-aminoquinoline analogs as antimalarial agents |